Eliapixant is a selective P2X3 receptor antagonist for the treatment of disorders associated with hypersensitive nerve fibersAdam J. Davenport, Oliver M. Fischer, Markus Koch et al.|Scientific Reports|2021Cited by 62
Discovery and Characterization of the Potent and Selective P2X4 Inhibitor <i>N</i> -[4-(3-Chlorophenoxy)-3-sulfamoylphenyl]-2-phenylacetamide (BAY-1797) and Structure-Guided Amelioration of Its CYP3A4 Induction ProfileStefan Werner, Andreas Steinmeyer, R.C. Hillig et al.|Journal of Medicinal Chemistry|2019Cited by 57